Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Hematuria | Research

The application of new complex indicators in the detection of urine

Authors: Ying-xiang Li, Yang Li, Si-yu Bao, Ning Xue, Xiao-qiang Ding, Yi Fang

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Accurate diagnosis and assessment of hematuria is crucial for the early detection of chronic kidney disease(CKD). As instability of urinary RBC count (URBC) often results with clinical uncertainty, therefore new urinary indexes are demanded to improve the accuracy of diagnosis of hematuria. In this study, we aimed to investigate the benefit of applying new complex indicators based on random urine red blood cell counts confirmed in hematuric kidney diseases.

Methods

All patients enrolled underwent renal biopsy, and their clinical information was collected. Urinary and blood biomedical indexes were implemented with red blood cell counts to derive complex indicators. Patients were divided into two groups (hematuria-dominant renal histologic lesions and non-hematuria-dominant renal histologic lesions) based on their renal pathological manifestations. The target index was determined by comparing the predictive capabilities of the candidate parameters for hematuric kidney diseases. Hematuria stratification was divided into four categories based on the scale of complex indicators and distributional features. The practicality of the new complex indicators was demonstrated by fitting candidate parameters to models comprising demographic information.

Results

A total of 1,066 cases (678 hematuria-dominant renal histologic lesions) were included in this study, with a mean age of 44.9 ± 15 years. In differentiating hematuria-dominant renal histologic lesion from the non-hematuria-dominant renal histologic lesion, the AUC value of “The ratio of the random URBC to 24-h albumin excretion” was 0.76, higher than the standard approach of Lg (URBC) [AUC = 0.744] (95% Confidence interval (CI) 0.712 ~ 0.776). The odds ratio of hematuria-dominant renal histologic lesion (Type I) increased from Q2 (3.81, 95% CI 2.66 ~ 5.50) to Q4 (14.17, 95% CI 9.09 ~ 22.72). The predictive model, composed of stratification of new composite indexes, basic demographic characteristics, and biochemical parameters, performed best with AUC value of 0.869 (95% CI 0.856–0.905).

Conclusion

The new urinary complex indicators improved the diagnostic accuracy of hematuria and may serve as a useful parameter for screening hematuric kidney diseases.
Literature
1.
go back to reference Xue N, Zhang X, Teng J, Fang Y, Ding XA. Cross-sectional study on the Use of Urinalysis for Screening Early-Stage Renal Insufficiency. Nephron. 2016;132:335–41.CrossRefPubMed Xue N, Zhang X, Teng J, Fang Y, Ding XA. Cross-sectional study on the Use of Urinalysis for Screening Early-Stage Renal Insufficiency. Nephron. 2016;132:335–41.CrossRefPubMed
2.
go back to reference Higashihara E, Nishiyama T, Horie S, Marumo K, Mitarai T, Koyama T, Matsuyama T, Ito K, Yuno T. Working Group for the creation of Hematuria Guidelines. Hematuria: definition and screening test methods. Int J Urol. 2008;15(4):281–4.CrossRefPubMed Higashihara E, Nishiyama T, Horie S, Marumo K, Mitarai T, Koyama T, Matsuyama T, Ito K, Yuno T. Working Group for the creation of Hematuria Guidelines. Hematuria: definition and screening test methods. Int J Urol. 2008;15(4):281–4.CrossRefPubMed
3.
go back to reference Kavuru V, Vu T, Karageorge L, Choudhury D, Senger R, Robertson J. Dipstick analysis of urine chemistry: benefits and limitations of dry chemistry-based assays. Postgrad Med. 2020;132(3):225–33.CrossRefPubMed Kavuru V, Vu T, Karageorge L, Choudhury D, Senger R, Robertson J. Dipstick analysis of urine chemistry: benefits and limitations of dry chemistry-based assays. Postgrad Med. 2020;132(3):225–33.CrossRefPubMed
4.
go back to reference Tsai JJ, Yeun JY, Kumar VA, Don BR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis. 2005;46(5):820–9.CrossRefPubMed Tsai JJ, Yeun JY, Kumar VA, Don BR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis. 2005;46(5):820–9.CrossRefPubMed
5.
go back to reference Humphries RM, Abbott AN, Hindler JA. Understanding and addressing CLSI breakpoint revisions: a primer for Clinical Laboratories. J Clin Microbiol. 2019;57(6):e00203–19.CrossRefPubMedPubMedCentral Humphries RM, Abbott AN, Hindler JA. Understanding and addressing CLSI breakpoint revisions: a primer for Clinical Laboratories. J Clin Microbiol. 2019;57(6):e00203–19.CrossRefPubMedPubMedCentral
6.
go back to reference Barocas DA, Boorjian SA, Alvarez RD, Downs TM, Gross CP, Hamilton BD, Kobashi KC, Lipman RR, Lotan Y, Ng CK, Nielsen ME, Peterson AC, Raman JD, Smith-Bindman R, Souter LH. Microhematuria: AUA/SUFU Guideline. J Urol. 2020;204(4):778–86.CrossRefPubMed Barocas DA, Boorjian SA, Alvarez RD, Downs TM, Gross CP, Hamilton BD, Kobashi KC, Lipman RR, Lotan Y, Ng CK, Nielsen ME, Peterson AC, Raman JD, Smith-Bindman R, Souter LH. Microhematuria: AUA/SUFU Guideline. J Urol. 2020;204(4):778–86.CrossRefPubMed
7.
go back to reference Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H. Persistent hematuria and kidney Disease Progression in IgA Nephropathy: a Cohort Study. Am J Kidney Dis. 2020;76(1):90–9.CrossRefPubMed Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H. Persistent hematuria and kidney Disease Progression in IgA Nephropathy: a Cohort Study. Am J Kidney Dis. 2020;76(1):90–9.CrossRefPubMed
8.
go back to reference Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS. ; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20 – 9. https://doi.org/10.1056/NEJMoa1114248. Erratum in: N Engl J Med. 2012 Aug 16;367(7):681. Erratum in: N Engl J Med. 2012;367(21):2060. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS. ; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20 – 9. https://​doi.​org/​10.​1056/​NEJMoa1114248. Erratum in: N Engl J Med. 2012 Aug 16;367(7):681. Erratum in: N Engl J Med. 2012;367(21):2060.
9.
go back to reference Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, Heinemann L, Schleicher E. Definition, classification and diagnosis of diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019;127(01):1–S7. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, Heinemann L, Schleicher E. Definition, classification and diagnosis of diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019;127(01):1–S7.
10.
go back to reference Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70(691):90–1.CrossRefPubMedPubMedCentral Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70(691):90–1.CrossRefPubMedPubMedCentral
11.
go back to reference Wu Y, Zhang J, Wang Y, Wang T, Han Q, Guo R, Zhang R, Ren H, Zhu Y, Xu H, Li L, Tong N, Liu F. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study. J Endocrinol Invest. 2020;43(9):1213–20.CrossRefPubMed Wu Y, Zhang J, Wang Y, Wang T, Han Q, Guo R, Zhang R, Ren H, Zhu Y, Xu H, Li L, Tong N, Liu F. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study. J Endocrinol Invest. 2020;43(9):1213–20.CrossRefPubMed
12.
go back to reference Fogazzi GB, Bosan IB. Garigali G.A theoretical and practical course on urine microscopy in Nigeria: a model for nephrological skill transfer. Nephron Clin pract. 2011;117(4):C398–402.CrossRefPubMed Fogazzi GB, Bosan IB. Garigali G.A theoretical and practical course on urine microscopy in Nigeria: a model for nephrological skill transfer. Nephron Clin pract. 2011;117(4):C398–402.CrossRefPubMed
13.
go back to reference Vedula R, Iyengar AA. Approach to diagnosis and management of Hematuria. Indian J Pediatr. 2020;87(8):618–24.CrossRefPubMed Vedula R, Iyengar AA. Approach to diagnosis and management of Hematuria. Indian J Pediatr. 2020;87(8):618–24.CrossRefPubMed
14.
go back to reference Hicks J, Mierau G, Wartchow E, Eldin K. Renal diseases associated with hematuria in children and adolescents: a brief tutorial. Ultrastruct Pathol. 2012;36(1):1–18.CrossRefPubMed Hicks J, Mierau G, Wartchow E, Eldin K. Renal diseases associated with hematuria in children and adolescents: a brief tutorial. Ultrastruct Pathol. 2012;36(1):1–18.CrossRefPubMed
15.
go back to reference Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention. Front Med (Lausanne). 2021;7:582272.CrossRefPubMed Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention. Front Med (Lausanne). 2021;7:582272.CrossRefPubMed
16.
go back to reference Palsson R, Srivastava A, Waikar SS. Performance of the Automated Urinalysis in Diagnosis of Proliferative Glomerulonephritis. Kidney Int Rep. 2019 Feb 12;4(5):723–727. Palsson R, Srivastava A, Waikar SS. Performance of the Automated Urinalysis in Diagnosis of Proliferative Glomerulonephritis. Kidney Int Rep. 2019 Feb 12;4(5):723–727.
17.
go back to reference Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989 Feb;141(2):350–5. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989 Feb;141(2):350–5.
18.
go back to reference Cho H, Yoo J, Kim H, Jang H, Kim Y, Chae H. Diagnostic characteristics of urinary red blood cell distribution Incorporated in UF-5000 for differentiation of glomerular and non-glomerular hematuria. Ann Lab Med. 2022;42(2):160–8.CrossRefPubMedPubMedCentral Cho H, Yoo J, Kim H, Jang H, Kim Y, Chae H. Diagnostic characteristics of urinary red blood cell distribution Incorporated in UF-5000 for differentiation of glomerular and non-glomerular hematuria. Ann Lab Med. 2022;42(2):160–8.CrossRefPubMedPubMedCentral
19.
go back to reference Ercan M, Akbulut ED, Abuşoğlu S, Yilmaz FM, Oğuz EF, Topçuoğlu C. Öztekin V and Boğdaycioğlu N: Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to Urinalysis. Clin Biochem. 2015;48:919–22.CrossRefPubMed Ercan M, Akbulut ED, Abuşoğlu S, Yilmaz FM, Oğuz EF, Topçuoğlu C. Öztekin V and Boğdaycioğlu N: Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to Urinalysis. Clin Biochem. 2015;48:919–22.CrossRefPubMed
21.
go back to reference Nakayama K, Ohsawa I, Maeda-Ohtani A, Murakoshi M, Horikoshi S, Tomino Y. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal. 2008;22(2):114–8.CrossRefPubMedPubMedCentral Nakayama K, Ohsawa I, Maeda-Ohtani A, Murakoshi M, Horikoshi S, Tomino Y. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal. 2008;22(2):114–8.CrossRefPubMedPubMedCentral
22.
go back to reference You-Hsien Lin H, Yen CY, Lim LM, Hwang DY, Tsai JC, Hwang SJ, Hung CC, Chen HC. Microscopic haematuria and clinical outcomes in patients with stage 3–5 nondiabetic chronic kidney disease. Sci Rep. 2015 Oct;16:5:15242. You-Hsien Lin H, Yen CY, Lim LM, Hwang DY, Tsai JC, Hwang SJ, Hung CC, Chen HC. Microscopic haematuria and clinical outcomes in patients with stage 3–5 nondiabetic chronic kidney disease. Sci Rep. 2015 Oct;16:5:15242.
23.
go back to reference Fritzenwanker M, Grabitz MO, Arneth B, Renz H, Imirzalioglu C, Chakraborty T, Wagenlehner F. Comparison of Urine Flow Cytometry on the UF-1000i System and Urine Culture of Urine Samples from Urological Patients.Urol Int. 2021 Dec29:1–10. Fritzenwanker M, Grabitz MO, Arneth B, Renz H, Imirzalioglu C, Chakraborty T, Wagenlehner F. Comparison of Urine Flow Cytometry on the UF-1000i System and Urine Culture of Urine Samples from Urological Patients.Urol Int. 2021 Dec29:1–10.
24.
go back to reference Babcock JG, Lippert LE, Derse-Anthony CP, Mechling M, Hess JR. A hypotonic storage solution did not prolong the viability of RBCs. Transfusion. 2000ug;40(8):994-9. Babcock JG, Lippert LE, Derse-Anthony CP, Mechling M, Hess JR. A hypotonic storage solution did not prolong the viability of RBCs. Transfusion. 2000ug;40(8):994-9.
25.
go back to reference Köhler H, Wandel E, Brunck B. Acanthocyturia–a characteristic marker for glomerular bleeding. Kidney Int. 1991;40(1):115–20.CrossRefPubMed Köhler H, Wandel E, Brunck B. Acanthocyturia–a characteristic marker for glomerular bleeding. Kidney Int. 1991;40(1):115–20.CrossRefPubMed
26.
go back to reference Bauer L, Emrich IE, Pickering JW, Untersteller K, Sandermann F, Rogacev KS, Seiler-Mussler S, Fliser D, Heine GH. Best Albuminuria measurement to Predict Cardiovascular and renal events. Am J Nephrol. 2016;43(5):383–8.CrossRefPubMed Bauer L, Emrich IE, Pickering JW, Untersteller K, Sandermann F, Rogacev KS, Seiler-Mussler S, Fliser D, Heine GH. Best Albuminuria measurement to Predict Cardiovascular and renal events. Am J Nephrol. 2016;43(5):383–8.CrossRefPubMed
27.
go back to reference Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 2013;84(3):622–3.CrossRefPubMed Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 2013;84(3):622–3.CrossRefPubMed
28.
go back to reference Kidney Disease. Improving global outcomes (KDIGO) glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276. Kidney Disease. Improving global outcomes (KDIGO) glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1–S276.
29.
go back to reference Bacârea A, Fekete GL, Grigorescu BL, Bacârea VC. Discrepancy in results between dipstick urinalysis and urine sediment microscopy. Exp Ther Med. 2021;21(5):538.CrossRefPubMedPubMedCentral Bacârea A, Fekete GL, Grigorescu BL, Bacârea VC. Discrepancy in results between dipstick urinalysis and urine sediment microscopy. Exp Ther Med. 2021;21(5):538.CrossRefPubMedPubMedCentral
Metadata
Title
The application of new complex indicators in the detection of urine
Authors
Ying-xiang Li
Yang Li
Si-yu Bao
Ning Xue
Xiao-qiang Ding
Yi Fang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03087-4

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine